Report published by Infosys.
As part of its study Amplifying Human Potential: Towards Purposeful Artificial Intelligence, Infosys commissioned independent research to investigate the approach and attitudes that senior decisionmakers in large organizations have towards AI technology and how they see the future application and development of AI in their industries. As part of the research, 10 industries were surveyed, including Retail, Fast Moving Consumer Goods (FMCG), Utilities, Financial Services, Healthcare, Pharmaceuticals and Life Sciences, Manufacturing, Telecoms, Automotive and Aerospace, and the Public Sector. This report is a glimpse into the findings specific to the healthcare sector.
The use of AI in the healthcare sector presents an exciting opportunity for organizations to drastically improve care in a short period of time, while saving cost. However, they would need to carefully consider how AI deployment could affect their workforce and ensure that the proper ethical checks for autonomous systems are in place. While AI systems will become increasingly common in healthcare organizations, they will exist to support people in their jobs. For instance, AI will optimize clinical processes, such as recording patients’ vital signs or analyzing scans and samples, but the doctor will decide the final line of treatment. When developing drugs, scientists choose target molecules from a set of possible candidates using instinct or guesswork. AI can do that much more efficiently and effectively, but it would still be an “experimentalist’s helper”. AI will enable healthcare professionals to understand diseases faster and make better clinical decisions, and it will help researchers innovate quickly by failing fast en route. The purpose of AI will be to augment natural intelligence, and its role will always be subordinate to the human’s.
Read the article at